SMMT — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

27.78

Margin Of Safety %

Put/Call OI Ratio

0.47

EPS Next Q Diff

-0.04

EPS Last/This Y

0.58

EPS This/Next Y

-0.03

Price

13.95

Target Price

29.06

Analyst Recom

1.76

Performance Q

-18.6

Upside

-204.3%

Beta

-1.24

Ticker: SMMT

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-13	SMMT	15.29	0.58	0.10	110422
2026-07-14	SMMT	15.47	0.58	0.05	111823
2026-07-15	SMMT	15.06	0.57	0.31	112419
2026-07-16	SMMT	13.76	0.56	0.09	112703
2026-07-17	SMMT	13.81	0.51	0.70	118125
2026-07-20	SMMT	13.52	0.61	0.08	96993
2026-07-21	SMMT	14.62	0.55	0.91	105588
2026-07-22	SMMT	14.75	0.54	0.41	111334
2026-07-23	SMMT	14.97	0.54	1.14	113267
2026-07-24	SMMT	13.66	0.55	0.23	115434
2026-07-27	SMMT	13.1	0.54	0.10	108118
2026-07-28	SMMT	12.59	0.52	0.27	112554
2026-07-29	SMMT	12.79	0.52	0.09	113651
2026-07-30	SMMT	13.45	0.48	0.15	119990
2026-07-31	SMMT	13.04	0.48	0.10	120736
2026-08-03	SMMT	13.04	0.48	0.09	118655
2026-08-04	SMMT	13.77	0.48	0.36	120572
2026-08-05	SMMT	13.53	0.47	0.23	126697
2026-08-06	SMMT	13.54	0.47	1.37	127681
2026-08-07	SMMT	13.92	0.47	1.27	128289
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-07-13	SMMT	15.31	62.2	-	-0.82
2026-07-14	SMMT	15.43	62.2	-	-0.82
2026-07-15	SMMT	15.07	62.2	-	-0.82
2026-07-16	SMMT	13.75	62.2	-	-0.82
2026-07-17	SMMT	13.81	62.2	-	-0.82
2026-07-20	SMMT	13.51	62.2	-	-0.82
2026-07-21	SMMT	14.63	62.2	-	-0.82
2026-07-22	SMMT	14.75	62.2	-	-0.82
2026-07-23	SMMT	14.97	62.2	-	-0.82
2026-07-24	SMMT	13.69	5.3	-	-0.82
2026-07-27	SMMT	13.10	5.3	-	-0.82
2026-07-28	SMMT	12.55	9.1	-	-0.83
2026-07-29	SMMT	12.80	6.7	-	-0.86
2026-07-30	SMMT	13.45	6.7	-	-0.86
2026-07-31	SMMT	13.03	6.7	-	-0.86
2026-08-03	SMMT	13.05	6.7	-	-0.86
2026-08-04	SMMT	13.05	6.7	-	-0.86
2026-08-05	SMMT	13.54	6.7	-	-0.86
2026-08-06	SMMT	13.54	6.7	-	-0.86
2026-08-07	SMMT	13.95	6.7	-	-0.86
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-07-13	SMMT	1.23	1.34	30.48
2026-07-14	SMMT	1.23	1.34	30.48
2026-07-15	SMMT	1.23	1.34	30.48
2026-07-16	SMMT	1.23	1.34	30.48
2026-07-17	SMMT	1.23	1.34	30.48
2026-07-20	SMMT	1.23	1.08	30.48
2026-07-21	SMMT	1.23	1.08	30.48
2026-07-22	SMMT	1.23	1.08	30.48
2026-07-23	SMMT	1.23	1.08	30.48
2026-07-24	SMMT	1.23	1.08	30.48
2026-07-27	SMMT	1.23	0.81	28.55
2026-07-28	SMMT	1.23	0.81	28.55
2026-07-29	SMMT	1.23	0.81	28.55
2026-07-30	SMMT	1.23	0.81	28.55
2026-07-31	SMMT	1.23	0.81	28.55
2026-08-03	SMMT	1.20	0.80	27.78
2026-08-04	SMMT	1.20	0.80	27.78
2026-08-05	SMMT	1.20	0.80	27.78
2026-08-06	SMMT	1.20	0.80	27.78
2026-08-07	SMMT	1.20	0.80	27.78
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.21

Avg. EPS Est. Current Quarter

-0.22

Avg. EPS Est. Next Quarter

-0.25

Insider Transactions

1.2

Institutional Transactions

0.8

Beta

-1.24

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

62.2

Max Drawdown 5-Year %

-91.8

Target Price

29.06

P/E

Forward P/E

PEG

P/S

P/B

17.58

P/Free Cash Flow

EPS

-1.12

Average EPS Est. Cur. Y

-0.86

EPS Next Y. (Est.)

-0.89

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.43

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-100

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.03

EBIT Estimation

◆ SMMT Healthcare

$13.96

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

2/20

Pullback

15/25

Volume

11/15

Valuation

12/20

TP/AR

1/10

Options

7/10

RSI

49.3

Range 1M

46.6%

Sup Dist

4.4%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

1/25

Growth

12/30

Estimates

0/20

Inst/Vol

3/15

Options

4/10

EPS Yr

21.8%

EPS NY

1.9%

52W%

9.5%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +108.2% upside

Quality

2/30

Valuation

15/30

Growth

9/25

Stability

7/10

LT Trend

1/5

Upside

+108.2%

Quality

SMMT — P/E HistoricalBiotechnology

Summit Therapeutics Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 265

Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis for the treatment of non-small lung cancer (NSCLC) and colorectal cancer (CRC). The company has also combined ivonescimab with chemotherapy, which is in phase III clinical trial for the patients with epidermal growth factor receptor, mutated, and locally advanced or metastatic non-squamous NSCLC; first-line metastatic NSCLC; and first-line unresectable metastatic CRC. It markets its products in the United states, Canada, Europe, Japan, Latin America, Middle East, and Africa. The company was founded in 2003 and is headquartered in Miami, Florida.

SMMT

Latest News

—

Caricamento notizie per SMMT…

stock quote shares SMMT – Summit Therapeutics Inc Stock Price stock today

news today SMMT – Summit Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch SMMT – Summit Therapeutics Inc yahoo finance google finance

stock history SMMT – Summit Therapeutics Inc invest stock market

stock prices SMMT premarket after hours

ticker SMMT fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: SMMT

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y